Medical Conditions

My Baby's Vascular Tumor Is Causing Blood Clotting Problems (Kasabach-Merritt)

Editorially reviewed | Sources: NIH, CHOP, NORD|Updated June 2026

The short answer

Kasabach-Merritt phenomenon (KMP) is a rare but serious complication where certain vascular tumors (kaposiform hemangioendothelioma or tufted angioma — not common infantile hemangiomas) trap platelets and clotting factors, leading to dangerously low platelet counts and a bleeding disorder. KMP is a medical emergency that requires hospitalization and specialized treatment. Despite being frightening, modern treatment with sirolimus and other medications has significantly improved outcomes. Most children respond well to treatment, though the vascular tumor may not fully resolve.

Thousands of parents search for this exact thing. You are not alone.

By Age

What to expect by age

0-3 months (acute presentation)

KMP typically presents in infancy with a rapidly enlarging, firm, purple vascular mass that becomes painful and tense. The baby may develop bruising, petechiae (tiny red dots on the skin), and signs of bleeding due to severely low platelets. Blood tests show very low platelet counts (often below 10,000) and elevated D-dimer. This is a medical emergency requiring immediate hospitalization. Treatment typically begins with sirolimus and sometimes corticosteroids.

3-12 months (treatment phase)

Treatment with sirolimus (and sometimes vincristine for resistant cases) usually leads to gradual improvement in platelet counts and shrinkage of the tumor over weeks to months. Blood work is monitored closely. The tumor may change from purple and tense to softer and lighter as it responds to treatment. Side effects of medications are monitored. Most infants respond within 2-4 weeks, though treatment may continue for months to years.

1-3 years (ongoing management)

Even after the KMP resolves (platelets normalize), the underlying vascular tumor often persists as a residual mass. Treatment with sirolimus may continue for an extended period. The vascular anomalies team will determine when it is safe to wean medication. Some residual mass may be managed with compression garments or additional interventions.

3 years+

Long-term follow-up is important. The residual vascular tumor may cause chronic pain, limb length discrepancy, or cosmetic concerns. Physical therapy may be needed if a limb is affected. Most children who survive the acute KMP episode do well long-term, though they need continued monitoring by a vascular anomalies center.

What Should You Do?

When to take action

Probably normal when...
  • Your baby is being treated for KMP and platelet counts are improving with medication
  • The vascular mass is shrinking and becoming softer on treatment
  • Your child has a residual vascular tumor after KMP resolution and it is being monitored
Mention at your next visit when...
  • The vascular mass seems to be growing or becoming more purple and tense again
  • Your baby is developing new bruises or petechiae while on treatment
  • The mass is causing your baby pain or discomfort
  • You have questions about how long treatment needs to continue
Act now when...
  • Your baby is bleeding (from nose, mouth, or a wound) that does not stop — call 911 or go to the emergency room immediately
  • Your baby has a rapidly expanding vascular mass with new bruising — this is a medical emergency
  • Your baby develops a high fever while on immunosuppressive medication — seek immediate medical evaluation
  • Your baby seems very lethargic, pale, or is breathing rapidly — these may be signs of anemia from blood loss and need urgent care

Sources

Trust your instincts. If something feels wrong, reach out to your pediatrician.

Worrying about your baby means you care. That is a good thing.

My Baby Has a Vascular Malformation (Port-Wine Stain or Deeper)

Vascular malformations are structural abnormalities of blood vessels or lymph vessels that are present at birth (though some become apparent later). Unlike hemangiomas, which grow rapidly and then shrink, vascular malformations grow proportionally with the child and do not go away on their own. They are classified by the type of vessel involved: capillary (port-wine stains), venous, lymphatic, or arteriovenous. Most are benign and manageable, but the approach depends on the type, location, and whether associated conditions are present (such as Sturge-Weber syndrome with facial port-wine stains).

My Baby's Head Shape Looks Abnormal

Many babies develop temporary head shape irregularities that are completely normal. A cone-shaped head from vaginal delivery reshapes within days. Mild positional flattening (plagiocephaly) from sleeping on the back is very common and usually improves with repositioning and tummy time. However, head shape changes involving ridges, a persistently bulging fontanelle, or rapid head growth changes should be evaluated to rule out craniosynostosis.

Achondroplasia (Dwarfism) in Babies

Achondroplasia is the most common form of short-limbed dwarfism, affecting about 1 in 15,000 to 40,000 births. It is caused by a mutation in the FGFR3 gene and is usually apparent at birth with characteristic features including short limbs, a larger head, and a prominent forehead. Intelligence is normal. With monitoring for specific complications and supportive care, children with achondroplasia lead full, active, and independent lives.

Adenoid Hypertrophy and Breathing

Adenoids are lymphoid tissue located behind the nose that help fight infection in young children. When adenoids become enlarged (adenoid hypertrophy), they can block the nasal airway, causing chronic mouth breathing, snoring, nasal speech, and sleep-disordered breathing. Enlarged adenoids are most common between ages 2-7 and are a leading cause of obstructive sleep apnea in young children. Treatment ranges from watchful waiting and nasal steroids to surgical removal (adenoidectomy) if breathing or sleep is significantly affected.

How to Advocate for Your Child's Needs

You know your child better than anyone, and your observations matter. If you feel something is not right with your child's development or health, you have every right to ask questions, request evaluations, and seek second opinions. Advocating for your child is not being difficult - it is being a good parent.

Air Quality and Baby Health

Babies and young children are more vulnerable to air pollution than adults because they breathe faster, their lungs are still developing, and they spend more time close to the ground where some pollutants concentrate. The EPA recommends keeping babies indoors when the Air Quality Index (AQI) exceeds 100 (orange level). During wildfire smoke events, keep windows closed, use air purifiers with HEPA filters, and monitor your child for coughing, wheezing, or difficulty breathing. Long-term exposure to air pollution can affect lung development.